Related Experiment Video
Updated: Apr 17, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.3K
The association between plasma visfatin levels and ED
Ö F Karataş1, M E Yıldırım1, H T Celik2
1Department of Urology, School of Medicine, Turgut Özal University, Ankara, Turkey.
International Journal of Impotence Research
|February 20, 2015
Summary
This study found no significant difference in visfatin levels between men with erectile dysfunction (ED) and healthy controls. Further research is needed to understand visfatin
Area of Science:
- Biochemistry
- Cardiovascular Research
- Endocrinology
Background:
- Visfatin was initially identified as a potential biomarker for atherosclerosis, endothelial dysfunction, and vascular damage.
- Endothelial dysfunction is recognized as a significant factor contributing to erectile dysfunction (ED).
Purpose of the Study:
- To investigate serum visfatin levels in patients diagnosed with severe erectile dysfunction (ED).
- To explore the potential association between visfatin levels and the presence of ED.
Main Methods:
- A case-control study involving 41 severe ED patients and 36 healthy male controls.
- Fasting serum visfatin levels were quantified using the enzyme-linked immunosorbent assay (ELISA) method.
- Comparison of clinical (BMI, weight, height) and biochemical parameters (lipids, glucose) between groups.
Main Results:
- No statistically significant difference was observed in fasting visfatin levels between the ED patient group and the healthy control group (P=0.399).
- No significant differences were found in the analyzed clinical and biochemical parameters between the two groups.
Conclusions:
- Serum visfatin levels do not appear to differ significantly between men with severe ED and healthy individuals.
- Additional research is required to elucidate the role of visfatin in cardiometabolic diseases and its specific impact on erectile dysfunction.
Related Concept Videos
01:20Disorders of the Male Reproductive System
5.6K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.6K
01:17Male Sexual Response: Erection & Ejaculation
29.2K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
29.2K
01:23Infertility in Males
710
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
710
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
359
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
359